A former dealmaker at Lazard Ltd., one of Wall Street’s most prominent investment banks, is accused by US authorities of feeding tips on health-care deals to a friend’s network of insider traders, who generated $41 million of illicit profits.
Sign in to read the full article.
Sign in with Google